ClinicalTrials.Veeva

Menu

VAS Correlation With BMI

I

Istanbul University

Status and phase

Unknown
Phase 4

Conditions

Morbid Obesity

Treatments

Drug: Morphine

Study type

Interventional

Funder types

Other

Identifiers

NCT02017314
830458909

Details and patient eligibility

About

The aim of the study is to observe if any correlation between Body mass index and VAS values exists in patients who has gone under abdominal surgery.

Group I : Patients with BMI<30 Group II: Patients with BMI between 30 and 34.9 Group III: Patients with BMI between 35 and 39.9 Group IV: Patients with BMI between 40 and 49.9 Group V : Patients with BMI >50

After the end of surgery patients will be extubated and in the recovery room morphine PCA (patient-controlled analgesia) treatment will be started according to their adjusted body weight. When VAS values over 4,10 mg/kg Paracetamol IV will be used as an escape treatment. VAS values and Delivery and Demand of the PCA and additional need for analgesics will be recorded in the first 48 hours.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing abdominal surgery and who will be given PCA treatment for postoperative pain.

Exclusion criteria

  • patients younger than 18 years old, patients with uncompensated diabetes or related polyneuropathy, patients receiving antidepressants or have a diagnosis of depression

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 5 patient groups

Group 5
Active Comparator group
Description:
Patients with BMI \> 50
Treatment:
Drug: Morphine
Group IV
Active Comparator group
Description:
Patients with BMI between 40 and 49.9
Treatment:
Drug: Morphine
Group III
Active Comparator group
Description:
Patients with BMI between 35 and 39.9
Treatment:
Drug: Morphine
Group II
Active Comparator group
Description:
patients with BMI between 30 and 34.9
Treatment:
Drug: Morphine
Group I
Active Comparator group
Description:
Patients with BMI \<30
Treatment:
Drug: Morphine

Trial contacts and locations

1

Loading...

Central trial contact

guniz koksal, Ass.Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems